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ABSTRACT 
Infection can reduce feed intake, limit weight gain, and decrease muscle growth by directing 
nutrients away from protein accretion and towards an inflammatory response; however, it is 
unclear how maternal infection affects offspring skeletal muscle development. Additionally, it is 
unclear how viral infections mechanistically reduce skeletal muscle growth and protein 
accretion. Pregnant gilts were inoculated with PRRSV (P piglets) or sterile culture medium (C 
Piglets) at 80 days of gestation.  Offspring were euthanized at birth (d0) or at four weeks of age 
(d28). Samples from the longissimus dorsi (LD) and psoas major (PM) were used for gene 
expression, while the semitendinosus (ST) at d28 was used to determine muscle fiber area and 
number. At d0 relative LD weight was decreased (P=0.01) while PM was increased (P=0.01) in 
P piglets compared with C piglets. At d28, whole LD (P=0.01) and relative LD weight (P=0.03) 
decreased in P piglets compared with C piglets. Cell number decreased (P=0.04) while muscle 
fiber cross sectional area within ST increased (P=0.02) in P piglets compared with C piglets. At 
d0 in the LD, maternal PRRSV infection resulted in a shift towards more oxidative fiber type 
expression and a decrease in negative growth factors as myosin heavy chain (MHC) 2b (P=0.02), 
MHC2x (P=0.01), and myostatin (P=0.01) expression decreased in P piglets compared with C 
piglets. However, at d28, there were no differences in MHC expression. A shift towards more 
oxidative fiber types also occurred in the PM at d0, as MHC1 expression was increased (P=0.03) 
in P piglets compared with C piglets. Furthermore, an increase in positive growth factors was 
observed as myogenic differentiation 1 (P<0.01) and myogenin (P<0.01) increased while 
myostatin expression decreased (P=0.04) in P piglets compared with C piglets. These data 
suggest maternal PRRSV infection restricts in utero muscle fiber development.  
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Postnatal infection was evaluated in pigs inoculated with PRRSV or sterile culture medium 
(control) at 35 days of age. Pigs were maintained on similar diets and euthanized at 49 days of 
age. Samples from the LD and PM were used for gene expression, while the ST was used to 
determine muscle fiber cross sectional area and number. From 35 to 49 days of age, body weight 
gain (P<0.01) and feed intake (P<0.04) were reduced in PRRSV inoculated pigs compared with 
control pigs. However, feed to gain ratio was only reduced (P<0.01) the first week after 
inoculation in PRRSV inoculated pigs compared with control. Longissimus dorsi and ST weights 
were decreased (P<0.01) and relative PM weight was reduced (P<0.01) in pigs inoculated with 
PRRSV compared with control pigs. In addition, muscle fiber size of PRRSV inoculated pigs 
tended to be reduced (P=0.09) compared with control pigs, but muscle cell number was 
unaffected. In the PM, myostatin expression tended to be increased (P=0.08) while myogenic 
factor 5 (P=0.01) and insulin-like growth factor 1 (P=0.04) were decreased in pigs inoculated 
with PRRSV compared with control pigs. Infection had minimal effects on myogenic growth 
factors in the LD as myogenic differentiation factor 1 (MYOD) was increased (P<0.01) and IGF 
2 was decreased (P=0.04) in pigs inoculated with PRRSV compared with control pigs. Porcine 
reproductive and respiratory virus infection decreased muscle weights and cell size through a 
decrease in myogenic growth factor expression. However, differences between muscles suggest 
muscles may respond differently to PRRSV infection depending on their fiber type composition.  
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CHAPTER 1 
REVIEW OF LITERATURE 
INTRODUCTION 
In order to feed a population of 9 billion people in 2050, the world will need to produce 
more food with fewer resources. New efficient, practical, and profitable technologies need to be 
used in order to reach these demands.  Current technologies used in animal agricultural 
production focus on postnatal growth, improving live performance and lean muscle growth have 
led to more efficient animal production. Relatively less attention, however, is focused on prenatal 
growth, despite the fact that market animals spend roughly one-third of life in gestation. During 
gestation, formation of primary and secondary muscle fibers determines overall postnatal growth 
potential of skeletal muscle. Primary muscle formation is controlled by genetic factors, but 
secondary muscle formation can be altered by external influences such as maternal nutrition or 
maternal stress (Buckingham et al., 2003) Therefore, manipulations can occur in gestation to 
enhance or limit muscle growth efficiency.  
Stress is defined as a disruption in homeostasis resulting in positive or negative 
adaptations (Moberg, 2000). In response to immunological stress, an inflammatory response 
occurs in order to adapt to a pathogen (Black, 2003). While inflammation aids in destroying 
pathogenic structures through enhanced permeability of membranes (Watkins et al., 1995), 
inflammation can also be perceived as a negative adaptation as production of inflammatory 
cytokines (interlukin-6; IL-6, tumor necrosis factor alpha; TNF-α) directs nutrients away from 
tissue growth to support an immune defense (Johnson, 2002). The most dramatic repartitioning is 
observed in skeletal muscle (Escobar et al., 2004). While effects of inflammation on skeletal 
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muscle growth has been determined, the influence of inflammatory cytokines on prenatal muscle 
development is less clear.  
Unfortunately, maternal inflammatory responses due to infection are typical in swine 
production and can be linked to multiple diseases. The most noted has been porcine reproductive 
and respiratory syndrome virus (PRRSV). In the United States, PRRSV causes a $299 million 
loss in productivity per year within breeding herds alone (Zimmerman et al., 2012). Yet, it is 
unclear how PRRSV infection in pregnant dams affects developing offspring. Furthermore, 
PRRSV leads to lean growth deficiencies in growing pigs, causing them to finish with more fat 
cover at lighter weights (Stahly et al., 1997). But, it is unclear how postnatal PRRSV infection 
mechanistically down-regulates muscle development and decreases lean yield production. 
Without a better understanding of prenatal and postnatal infection, improvements in growth 
efficiency will be limited. This review of the current literature will lay the foundation to further 
investigate prenatal animal growth potential while detailing how immunological stress affects the 
molecular mechanisms that reduce growth. It will also discuss muscle growth and development, 
immunological stress, inflammation and its effects on muscle development.  
MUSCLE GROWTH AND DEVELOPMENT 
Embryogenesis is the process of embryo formation from fertilization and cleavage to fetal 
formation. There are three main events that occur during embryogenesis: gastrulation, 
neurulation, and segmentation/somitogenesis. During gastrulation, cells in the epiblast begin to 
replicate in Hensen’s Node, causing a thickened structure (primitive streak) to form parallel to 
the long axis of the embryo, proceeding from head to tail. The primitive streak then begins to 
deepen into a depression forming the primitive groove (Bachvarova et al., 1998). Epithelial 
mesenchymal transformation, transformation from epithelial cells into mesenchymal through 
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characteristic alterations, is necessary for proper formation of the primitive groove. Epithelial 
mesenchymal transformation is regulated by fibroblast growth factor (FGF), which aids in 
alterations of cell adhesion (Radisky, 2005). As migration of cells continues, three distinct germ 
layers form: ectoderm, mesoderm, and endoderm (Mundlos, 2010).  
Next, the edge of primitive groove becomes more pronounced, initiating neurulation 
(Copp et al., 2003). The two edges of the groove converge, resulting in an essential neural tube 
that acts as a structural unit to the notochord, which forms ventral to and outside of the neural 
tube through hedgehog signaling (Choi and Harfe, 2011). Along the neural tube, mesodermal 
cells begin to condense into blocks (somites). Somitogenesis is tightly governed by Hox genes, 
which produce transcription factors that define positional identity of tissues (Christ and Ordahl, 
1995). These transcription factors regulate cell adhesion, migration, cycle, and apoptosis. 
Positional identity of tissues derived from somites is specified by the expression pattern of Hox 
genes, which are regulated by an overlap in gradient of growth factors: Wingless-Int (Wnt) 
proteins (regulates 3’ Hox gene expression), FGF (regulates 5’ Hox gene expression), and 
retinoic acid (antagonizes FGF and enhances anterior 3’ Hox gene expression; (Maconochie et 
al., 1996)).  These genetically regulated pathways are essential to specify function of each cell. 
Muscle development is a highly regulated system and any minimal alterations could affect 
proper and optimal formation of muscle. 
COMMITMENT TO MATURATION 
Limb bud formation is essential for skeletal muscle development. Each limb arises from a 
small bud of mesodermal cells covered by surface ectoderm. In the progress zone of proliferating 
cells, FGF maintains proliferation and delays differentiation of mesoderm. As limb buds grow, 
medial cells are exposed to less FGF, resulting in mesenchymal condensation that becomes 
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cartilage (Mariani and Martin, 2003). During limb bud formation, cells become specified and 
enter myogenesis.  
Myogenesis consists of six well-defined steps: commitment/determination, migration, 
proliferation, differentiation, fusion, and maturation/hypertrophy. Cells begin myogenesis by 
expressing myogenic regulatory factor (MRF) genes, thus committing cells to become muscle 
(Ott et al., 1991). Muscle regulatory factors are transcription factors that interact with DNA and 
activate transcription of muscle specific genes such as myosin, actin, and titin (Buckingham, 
1992). An essential characteristic of muscle cells are Myf5 and MyoD as they determine muscle 
lineage. An increase in Myf5 and MyoD expression will stop cell proliferation and increase 
synthesis of myogenin. Expression of myogenin biochemically changes characteristics of 
differentiation and allows myoblast fusion to occur (Wang and Jaenisch, 1997).  
Muscle cell proliferation and migration are directed by FGF signaling. After migration, 
myoblasts continue to divide and increase in cell number through proliferation. Proliferation is 
regulated by peptide growth factors in the cell cycle. During G1-phase, myoblasts are in growth 
arrest and are most sensitive to external growth factors. Timing and concentrations of certain 
growth factors encourage cells to continue through the cell cycle and their absence will cause 
cells to exit the cell cycle and develop into specific tissues (Allen and Boxhorn, 1989). Growth 
factors that encourage muscle cell proliferation are insulin-like growth factor 1 (IGF-1) and FGF, 
while myostatin and tumor-necrosis factor alpha (TNF-α) inhibit proliferation (Glass, 2005).  
Myostatin, in particular, is a negative regulator specifically of skeletal muscle mass (Zhu 
et al., 2004). Myostatin inhibits proliferation by binding to activin type II receptors through 
divergent signaling cascades. First, Smad3 phosphorylation will increase, inhibiting production 
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of MyoD and myogenin. This inhibition stops differentiation within cells, restricting precursor 
cells from becoming myoblasts. Second, myostatin binding to activin type II receptor will 
activate and increase p21. This leads to inhibition of cyclin/CDK complex which is needed to 
move into S phase of the growth cycle (Lee, 2004).  
Regulation of myogenic differentiation is regulated by Notch/Hes pathway (Kitamura et 
al., 2007). Active Notch signaling suppresses MyoD transcription, preparing cells for fusion as 
they halt cellular division (Shawber et al., 1996). Myoblast fusion is promoted by IGF-1 and 
integrin (Yun and Wold, 1996). Myotube fusion results in increased transcription of muscle 
specific genes: myogenin, MRF4, muscle creatine kinase (MCK), and the thick and thin filament 
proteins, myosin and actin, respectively (Sabourin and Rudnicki, 2000). After myoblasts fuse, 
they develop more muscle characteristics as they mature to reach full functionality. During 
maturation, there is an up-regulation of myofibril proteins and assembly of myofibrils into 
functional muscle units. Muscle development is a complex system that is highly dependent on 
specific growth promoter and repressor signaling during fetal development (Butler-Browne et al., 
1990). The fetus relies on maternal health and nutrient regulation to maintain proper balance and 
signaling of muscle growth.  
PRIMARY AND SECONDARY FIBER FORMATION 
Muscle fiber fusion occurs in a series of waves with a portion of myoblasts fusing to form 
myotubes while other myoblasts continue to proliferate.  Primary myotubes (fibers) develop first 
and act as scaffolding for secondary myotubes to form, organizing their alignment, and aiding in 
proper fusion (Choi et al., 2008). Primary myotubes are thought to mature into slower 
contracting, oxidative muscle fibers expressing  myosin heavy chain (MHC) 1 in adult skeletal 
muscle, while secondary muscle fibers form the faster contracting, more glycolytic fibers that 
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express MHC II isoforms (Alnaqeeb and Goldspink, 1987). In swine, there may be as many as 
20 secondary muscle fibers formed for each primary muscle fiber (Gerrard and Grant, 2006), 
therefore secondary muscle fibers have a large effect on growth potential of an animal. Primary 
muscle fiber development is independent from environmental cues, meaning maternal factors 
such as immunological stress may not affect their development (Qu et al., 1998; Yaffe, 1968).  
Conversely, secondary muscle fiber formation is responsive to external influences; 
therefore, external factors can manipulate total muscle fiber number (Wigmore and Stickland, 
1983). Secondary muscle fibers develop as innervation begins, making their development 
dependent on innervation (Fredette and Landmesser, 1991). In an aneural system, a myoblast 
cannot differentiate into a secondary myofiber; however, myotubes can degenerate and be 
replaced with connective tissue through atrophy (Jirmanová and Zelená, 1970). Furthermore, 
maternal nutrition is crucial for fetal muscle development because organogenesis and other tissue 
development takes precedence over skeletal muscle development (Zhu et al., 2010). If maternal 
undernutrition occurs during mid to late gestation, secondary muscle fiber formation is decreased 
in offspring in order to repartition necessary nutrients to organogenesis, reducing postnatal 
growth rate (Dwyer et al., 1994).  
Similar to maternal under-nutrition, in an overfed, obese maternal nutrition model, 
secondary muscle fiber formation was decreased in offspring (Du et al., 2010). This reduction in 
secondary fiber formation was attributed to chronic inflammation associated with production of 
inflammatory cytokines (Tong et al., 2009), and not to a direct effect of nutritional excess on the 
fetus. Given this reduction in muscle fiber formation in obese dams, it can be speculated that 
maternal infection will induce inflammation symptoms on the fetus and reduce muscle fiber 
number. 
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FIBER TYPES AND POSTNATAL GROWTH 
Muscle fiber types can be defined by their metabolic, contractile and morphological 
characteristics and divided into four different fiber types based on MHC isoform; MHC 1, MHC 
2a, MHC 2x, and MHC 2b (Schiaffino et al., 1989). Among the 4 types, MHC 1 fibers are 
slowest contracting, have many mitochondria, are darker in color, and have the greatest capacity 
for oxidative metabolism, while MHC 2b fibers are the fastest contracting fibers, have fewer 
mitochondria, are lightest in color, and have the greatest capacity for glycolytic metabolism. 
Myosin heavy chain 2a and 2x fibers are also fast contracting fibers, however, they are 
intermediate in many characteristics and color, and have mixed capacities for both oxidative and 
glycolytic metabolism (Ausoni et al., 1990). Muscles are developmentally comprised of different 
fiber types; however, each may be altered by neural, endocrine and physical stimuli.  
Postnatal muscle growth is achieved through hypertrophy or an increase in muscle cell 
size (Goss, 1966).  Both primary and secondary muscle fibers can increase in size; however, 
secondary muscle fibers or MHC 2 fibers experience more hypertrophic growth than primary, 
MHC 1, fibers (Ashmore et al., 1973). When growth inhibitors (e.g., myostatin) were deleted, the 
proportion of MHC 2x fibers increased 66 + 9% (P<0.01) in the semitendinosus, a muscle with 
mixed MHC fibers. In fact, the MHC 1 fiber population was reduced in the semitendinosus 
(Bouley et al., 2005).  This suggests MHC 2 fibers are more responsive to hypertrophic growth 
signals. Therefore, fewer MHC 2 fibers at birth will limit postnatal growth potential. 
Postnatal growth is highly dependent upon satellite cells as they supply new sources of 
DNA to support new protein synthesis during growth (Allen and Rankin, 1990). During satellite 
cell activation, Notch-1 translocates to the nucleus and causes proliferation of paired box (Pax) 3 
and Pax7 expressing satellite cells. Without Pax3 and Pax7, these cells die or exhibit cell-cycle 
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arrest. Through expression of Pax3 or Pax7, MyoD and myogenin increase expression, allowing 
a new myoblast to form and fuse (Buckingham, 2007).   
IMMUNOLOGICAL STRESS AND FETAL PROGRAMMING 
 During immunological stress, such as infection, an innate immune response occurs 
(Aderem and Ulevitch, 2000). Pattern-recognition receptors (PRR) such as toll-like receptors 
(TLR) recognize the molecular finger print of a pathogen and activate inflammatory responses. 
(Medzhitov, 2007; Sabroe et al., 2008). Macrophages and other immune cells express specific 
TLR. Once specific TLR bind a pathogen-associated molecular pattern, a cascade of events 
releases nuclear factor-kappa beta (NF-ĸβ), which translocates to the nucleus to increase 
expression of inflammatory cytokines, including TNF-α and IL-6 (Effros et al., 1991).  
Cytokines are synthesized in the cytoplasm, secreted by the endoplasmic reticulum, and 
induce a cast array of biological effects (Zhang and Kaufman, 2008). Specifically, TNF-α 
increases vascular permeability and stimulates local inflammation through increased membrane 
receptor function. Cytokines also induce increased internal temperature by mobilizing protein 
and energy in muscle and fat tissue; this decreases infectious replication (Moldawer and 
Copeland, 1997).  In general, these cytokines increase permeability in blood vessels, allowing 
more serum proteins to be transferred to infection sites to destroy pathogenic structures (Watkins 
et al., 1995).  
 Fetal programming is defined as developmental changes in structure or metabolism 
triggered by maternal stimuli during fetal development (Godfrey and Barker, 2001). Nutritional 
changes during gestation have been well-studied in terms of fetal programming but the effect of 
maternal infection is less well-understood. When Escherichia coli lipopolysaccharide, a well-
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defined model of immune system activation in rodents, was administered to pregnant mice, an 
increase in maternal circulation of IL-6 and TNF-α led to increased IL-6 and TNF-α levels in 
amniotic fluid, and decreased fetal neurodevelopment and survival (Collins et al., 1994). 
Furthermore, maternal inflammation due to infection has been correlated with low birth weight 
and higher incidence of premature birth (Rogers and Velten, 2011). Therefore, maternal infection 
can alter fetal development, but its effect on fetal muscle development is less clear. Maternal 
obesity models demonstrate low-grade inflammation including production of TNF-α and IL-6 
(Wei et al., 2008). These models have been shown to shift commitment of fetal mesenchymal 
stem cells away from a myogenic lineage (Du et al., 2010). However, mechanistic pathways to 
how inflammation decreases fetal myogenesis have yet to be defined. The cytokines IL-6 and 
TNF-α can negatively affect muscle development as they inhibit myogenic differentiation 
(Langen et al., 2001; Tong et al., 2009).  
INTERLEUKIN-6 AND MUSCLE GROWTH 
Specifically, IL-6 has been related to growth deficits in children and sarcopenia in elderly 
as it directly or indirectly mediates catabolic effects on skeletal muscle (DeBenedetti et al., 1997; 
Grimble, 2003; Haddad et al., 2005).  In transgenic mice exhibiting a 5-fold increase in 
circulating IL-6 concentrations, body weight was decreased 50-70% compared with non-
transgenic littermates due to reduced circulating IGF-1 levels. It has been suggested that IL-6 
may inhibit liver IGF-1 production or decrease ternary binding complex IGF-1 traveling in 
circulation. More importantly, decreased IGF-1 levels found in transgenic mice cannot be 
attributed to nutritional disorders as all mice maintained normal feed intake, therefore suggesting 
decreases in growth were due to increased IL-6 directly (DeBenedetti et al., 1997).  Furthermore, 
IL-6 infusion in rats resulted in muscle atrophy characterized by a loss of myofibrillar protein of 
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up to 17% (Haddad et al., 2005) compared to non-infused rats. In addition, when direct effects of 
IL-6 on skeletal muscle were examined, IL-6 reduced phosphorylation of ribosomal S6 kinase 
(60%) and signal transducer and activator of transcription 5 (33%); key regulators of cell growth 
(Dufner and Thomas, 1999).  
TUMOR NECROSIS FACTOR ALPHA AND MUSCLE GROWTH 
 Interveneous administration of TNF-α accelerated muscle protein degradation (García-
Martínez et al., 1993). Muscle growth can be directly and indirectly inhibited by TNF-α (Figure 
1.1). Directly, TNF-α has a catabolic effect on differentiated muscle through activation of NF-kB 
(Reid and Li, 2001). Binding of TNF-α to type 1 TNF-α receptors (TNFR1), activates NF-kB 
and up-regulates ubiquitin/proteasome pathway that is responsible for degradation of most 
intracellular protein (Mani and Gelmann, 2005). Proteasomes break down protein to peptides, 
which will be degraded into amino acids (Reid and Li, 2001). In addition, active NF-kB 
translocates to the nucleus to initiate transcription of cytokines and growth regulatory factors 
(Langen et al., 2001).  
 Moreover, TNF-α can indirectly reduce muscle development through insulin resistance 
(Reid and Li, 2001). Under normal conditions, insulin binds to insulin receptors on skeletal 
muscle stimulating intrinsic tyrosine kinase activity which auto-phosphorylates insulin receptor 
substrates. This leads to activation of phosphatidylinositol 3-kinase (PI3K), which increases 
phophoinositides that activate downstream kinases such as protein kinase B/Akt (Goodyear et al., 
1995). Phosphorylation of Akt substrate 160 inhibits glycogen synthase kinase 3, which 
stimulates translocation of glucose transporter type 4 (GLUT4) to cell membranes to allow 
glucose to enter cells where it is used in glycogen synthesis pathways (Kurth-Kraczek et al., 
1999).  In addition to its role in glucose metabolism, insulin is also a potent stimulator of muscle 
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protein accretion. Insulin functions in skeletal muscle by causing an up-regulation of protein 
synthesis via PI3K–mammalian target of rapamycin (mTOR) signaling pathway. When insulin 
binds to insulin receptors on the sarcolemma, insulin receptor substrate (IRS)-PI3K-Akt pathway 
is activated phosphorylating mTOR (Bolster et al., 2002). Activation of mTOR results in 
phosphorylation of downstream targets that ultimately increase the number of ribosomes to 
support protein synthesis during hypertrophy (Nader et al., 2005).  
 Cytokines, however, have the ability to disrupt insulin signaling through the IRS-PI3K-
Akt pathway, there by leading to insulin resistance (Hotamisligil, 2006). Because insulin is a 
strong stimulator of growth and shares a pathway with IGF, disruption could cause growth 
deficits. When specific skeletal muscle receptors (e.g., TNFR1 and TNFR2) bind to TNF-α 
tyrosine phosphorylation of insulin receptor substrate (IRS-1) is decreased. Furthermore, IRS-1 
serine phosphorylation increases (Bouzakri and Zierath, 2007). These two events result in 
increased degradation of IRS-1, reduced activation of PI3K, and reduced glucose uptake into 
cells (Pederson et al., 2001). Furthermore, when TNFR1 binds TNF-α, AMP-activated protein 
kinase (AMPK), a regulator of muscle metabolism and gene expression, is suppressed reducing  
skeletal muscle acetyl CoA carboxylase phosphorylation, fatty acid oxidation, glycogen 
metabolism, and glucose uptake decrease, all of which are linked to insulin resistance (Wei et al., 
2008). 
PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS 
 Increased expression of inflammatory cytokines in skeletal muscle has been investigated 
in many scenarios (Späte and Schulze, 2004), but the effects of viral infection are less well-
known. Furthermore, minimal research has shown lasting effects of maternal infection during 
pregnancy on a developing fetus. In the United States, PRRSV causes a $664 million loss in 
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productivity annually; with 45% of production loss occurring in breeding herds (Zimmerman et 
al., 2012). Animals infected with PRRSV exhibited reduced feed intake and growth due to 
immunological stress response (Sandberg et al., 2006). Immunological stress caused by PRRSV 
generates an inflammatory response consisting of increased production of inflammatory 
cytokines IL-6 and TNF-α production (Black, 2003). Escobar et. al. (2004) reported increased 
inflammatory cytokines from PRRSV infection led to increased myostatin expression that 
contributes to decreased protein accretion and reduced myofiber area in muscles of mixed MHC 
fiber composition. However, muscle inflammation targets a reduction in MHC 2 fiber number 
and size with minimal changes in MHC 1 fibers (Deschenes, 2004). Therefore, more information 
is needed to determine if growth restricted during immunological stress depends on fiber type 
composition.  
OBJECTIVES 
Maternal infection is common in animal pregnancy, but with minimal research in this 
area, expected outcomes and preventative measures to protect progeny are scarce. Information 
gained in this area is critical for preventing and treating developmental and health related 
problems. Furthermore, these results can help increase production efficiency by gaining a greater 
understanding of the importance of prenatal growth in livestock production.  
As reviewed, inflammatory cytokines inhibit myogenic differentiation through multiple 
pathways. Through this study we will determine if myogenic differentiation is inhibited in 
offspring of maternally infected dams to create reductions in muscle growth. Furthermore, we 
will establish a fundamental knowledge of the influence of maternal infection during pregnancy 
concerning the molecular basis of muscle growth and development. In addition, we can 
understand how maternal infection will affect overall production potential of animals. 
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Furthermore, defining mechanisms involved in inhibiting postnatal skeletal muscle protein 
accretion during infection is necessary to understand how specific muscles are growth restricted. 
With a thorough understanding of muscle growth inhibition during infection, nutrient 
requirements can be adjusted or new marketing techniques can be applied to reduce production 
loss.  
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FIGURES 
 
Figure 1.1. Tumor necrosis factor alpha (TNF-α) directly and indirectly inhibits skeletal muscle 
growth. Directly, TNF-α activates nuclear factor- κβ (NF- κβ), causing protein degradation 
through the ubiquitin/proteasome pathway.  Indirectly, TNF-α binds to specific muscle receptors 
and decreases tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), decreasing 
activation of phosphoinositide 3-kinase (PI3K). Adapted from Grounds et al. (2008). 
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CHAPTER 2 
EFFECTS OF MATERNAL INFECTION WITH PORCINE REPRODUCTIVE AND 
RESPIRATORY SYNDROME VIRUS ON MUSCLE GROWTH AND 
DEVELOPMENT IN PIGLETS 
ABSTRACT 
Infection stimulates nutrient repartitioning away from skeletal muscle to support the immune 
system, which can limit weight gain and decrease muscle growth. The effects of maternal 
infection and inflammation during pregnancy on offspring skeletal muscle development, 
however, are not well understood. Therefore, pregnant gilts were inoculated with porcine 
reproductive and respiratory syndrome virus (PRRSV) or sterile culture medium at 80 days of 
gestation.  Offspring were euthanized at birth (d0, n=58) or at four weeks of age (d28, n=24). 
Data were analyzed as a 2-way ANOVA with the fixed effects of inoculation and sex, with piglet 
serving as the experimental unit. At each age, offspring were weighed and longissimus dorsi 
(LD), psoas major (PM) and semitendinosus (ST) muscles were removed and weighed. Samples 
from the LD and PM were used for gene expression, while the ST at d28 was used to determine 
muscle fiber area and number. At d0, relative LD weight decreased (P=0.01) while relative PM 
increased (P=0.01) in piglets from PRRSV infected gilts (P) compared with piglets from control 
gilts (C). At d28, whole LD (P=0.01) and relative LD weight (P=0.03) decreased in P piglets 
compared with C piglets. Muscle fiber number decreased (P=0.04) while muscle fiber cross 
sectional area of ST increased (P=0.02) in P piglets compared with C piglets. At d0 in the LD, 
maternal PRRSV infection reduced expression of the glycolytic fiber types myosin heavy chain 
(MHC) 2b (P=0.02) and 2x (P<0.01). Furthermore, myostatin expression decreased (P=0.01) in P 
piglets compared with C piglets. However, at d28, there were no differences in MHC expression. 
A shift towards more oxidative fiber types occurred in the PM at d0, as MHC1 expression was 
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increased (P=0.03) in P piglets compared with C piglets. Furthermore, insulin-like growth factor 
(IGF) 2, myogenic differentiation 1 (MyoD) and myogenin expression increased (P<0.01) while 
myostatin expression decreased (P=0.04) in P piglets compared with C piglets. At d28, no 
differences in myogenic growth factors were observed in the PM and LD. Overall, increased 
IGF2 expression and decreased myostatin expression at d0 in the PM suggests increased 
hypertrophy in line with the increased muscle fiber size observed in the ST. However, maternal 
PRRSV infection restricted in utero muscle fiber development in piglets as evidenced by reduced 
muscle fiber number in P piglets, and therefore may limit skeletal muscle growth potential.  
Key words: maternal infection, muscle development, porcine reproductive and respiratory 
syndrome virus  
INTRODUCTION 
Infections are common in animal production and result in lost production and efficiency 
due to reduced feed intake (Sandberg et al., 2006). In addition, inflammatory cytokines such as 
interlukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α) direct nutrients away from tissue 
growth toward an inflammatory response (Johnson, 2002) with the most dramatic repartitioning 
away from skeletal muscle (Hasselgren et al., 2002; Strassmann et al., 1992). Inflammation can 
be extremely taxing on muscle growth in an infected animal; however, it is unclear how 
immunological stress in pregnancy affects skeletal muscle development and subsequent growth 
in offspring.  
In rodents, Escherichia coli lipopolysaccharide (LPS) is a well-defined model of immune 
system activation that results in synthesis of inflammatory cytokines (Urakubo et al., 2001). 
When LPS was administered to pregnant mice, increased maternal circulation of IL-6 and TNF-α 
increased IL-6 and TNF-α levels in amniotic fluid, and decreased fetal neurodevelopment and 
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survival. (Collins et al., 1994). As inflammatory cytokines IL-6 and TNF-α inhibit myogenic 
differentiation (Langen et al., 2001; Tong et al., 2009) and maternal cytokines have the ability to 
alter fetal development, skeletal muscle development of offspring may be limited by maternal 
infection. Prenatal development is especially crucial in skeletal muscle because muscle fiber 
number is set at or near birth (Dwyer et al., 1994). Animals born with fewer muscle fibers have 
slower, less efficient lean muscle growth (Dwyer et al., 1993). Therefore, the objective of this 
study was to determine the effect of maternal PRRSV infection on offspring skeletal muscle 
development and growth.  
MATERIALS AND METHODS 
Animal Procedures 
All animal procedures were approved by the Institutional Animal Care and Use 
Committee of University of Illinois and followed guidelines recommended in the Guide for the 
Care and Use of Agricultural Animals in Agricultural Research and Teaching (FASS, 2010). Ten 
PRRSV-free pregnant gilts from the University of Illinois Swine Research Center were delivered 
to the Edward R. Madigan Laboratory in five sets of two gilts each on day 70 of gestation 
between January and September 2013 (Table 2.1). Gilts were housed in isolated standard 
farrowing crates and fed 2.27 kg/d of a standard diet for gestating gilts (Table 2.2). Room 
temperature was maintained at 26.7ºC and a continuous water source was provided. Starting on 
day 73 of gestation, voluntary feed intake and rectal temperature of gilts were measured daily 
until farrowing. Feed intake was measured by weighing remaining feed in bowl from previous 
day. On day 80 of gestation, gilts were inoculated intranasally with PRRSV (5 mL of tissue 
culture infectious dose50 of strain P-129, Purdue University, West Lafayette, IN) or sterile culture 
medium (control, 5 mL Dulbecco’s phosphate buffered saline). Blood (10 mL) was collected 
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from an ear catheter 10ml/d for 14 consecutive days, then weekly until farrowing and 
immediately after farrowing to determine the presence of PRRSV with a qualitative test. The 
presence of PRRSV antibodies in the serum of all gilts was analyzed by the Veterinary 
Diagnostic Laboratory (University of Illinois, Urbana, Illinois) using a PRRSV-specific ELISA 
kit (IDEXX Laboratories, Westbrook, ME). This assay has 98.8% sensitivity and 99.9% 
specificity, with an S/P ratio of >0.4 indicating a positive sample. Serum samples from piglets, 
detailed below, were tested for PPRSV in the same manner.  
Six gilts were anesthetized on day 114 of gestation via intravenous injection with a 
combination of TKX (telazol:ketamine:xylazine, 4.4 mg/kg BW, Fort Dodge Animal Health, 
Fort Dodge, IA) followed by euthanasia via intravenous administration of an overdose of sodium 
pentobarbital (390 mg/ml Fatal Plus - administered at 1 ml/5 kg BW, Vortech Pharmaceuticals, 
Dearborn, MI). Caesarean sections were performed after euthanasia to collect piglets. From the 3 
control gilts, 34 piglets (20 males, 14 females) were collected. All tested PRRSV negative. From 
the 3 PRRSV infected gilts, 24 piglets (14 males, 10 females) were collected. Of these, 17 piglets 
were PRRSV negative (11 males, 6 females) and 7 piglets were PRRSV positive (3 males, 4 
females). 
Additionally, 4 gilts were allowed to farrow naturally. Piglets were subjected to normal 
processing that included trimming needle teeth, umbilical trimming and sanitation, and iron 
dextran injection (intramuscular injection at 100 mg, penicillin at 0.2 cc., Betadine Surgical 
Scrub, Purdue Products L.P, Stamford, CT). Testicles of male piglets remained intact. From the 2 
control gilts, 12 piglets (8 males, 4 females) were collected. All were PRRSV negative at birth 
and remained so throughout the study. From the 2 PRRSV infected gilts 12 piglets (7 males, 5 
females) were collected. Of these, 9 piglets were PRRSV negative (5 males, 4 females) and 3 
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piglets were PRRSV positive (2 males, 1 female) at birth. The piglets were weaned from gilts at 
2 days of age and housed in individual isolated cages. At this time, all piglets from gilts 
inoculated with PRRSV tested positive for PRRSV. Piglets were weighed daily and provided 360 
ml/kg body weight of a commercially available milk replacer (Advance Liqui-Wean, Milk 
Specialties, Prairie, MN). Milk replacer was delivered in 14 equal aliquots using an automatic 
delivery system as previously reported by Elmore et. al. (2014). At 28 days of age, piglets were 
anesthetized and euthanized using procedures similar to gilts.  
Growth Measurements and Sampling 
 At each time point (d0 and d28), body weight and crown-to-rump length was recorded for 
each piglet. The semitendinosus (ST), longissimus dorsi (LD), and psoas major (PM) were 
removed from the left side of the piglet and weighed. Three 100mg samples were collected from 
the LD and PM, placed in RNAlater (Ambion-Life Technologies, Grand Island, NY) and held at 
-80˚C until gene expression analysis. Samples of the LD were collected posterior to the spinalis 
dorsi muscle. 
Muscle cell number and size 
To determine muscle cell number and size, the ST from each piglet at d28 was anchored 
by string to a wooden stick to prevent shortening and held at 4˚C until rigor mortis was complete 
(approximately 24 hours). After 24 hours, the ST was submerged in approximately 8 mL of 10% 
neutralized buffered formalin (37% formaldehyde, Fischer Scientific, Fair Lawn, New Jersey). 
After 48 hours of submersion, the ST was sliced in half, perpendicular to the direction of the 
muscle fibers, and the cut face of the ST was traced on acetate paper. To determine the cross 
sectional area of the muscle the outlines were traced using an Intuos 4 Wacom tablet (PTK-840; 
Tokyo, Japan) into Adobe Photoshop CS5 Extended (Adobe Systems Incorporated, San Jose, 
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CA) and measured. Approximately 1 cm3 samples were collected from each ST to determine 
cross sectional area and muscle fiber number. Using these samples, 2 to 3, 7-μm sections per 
animal were cut perpendicular to the muscle fibers with a microtome, fixed to a glass slide and 
stained with hematoxylin and eosin. Five random images were captured for each section using a 
total magnification of 564X on an AMG Exos XL Microscope (EVOS, Bothell, WA). The area 
of all fibers in each of five images were measured using Adobe Photoshop CS5 Extended 
(Adobe Systems Incorporated, San Jose, CA) to determine an average cross sectional area of 
individual muscle fibers. Images were standardized to 100 µm scale bar; 440 pixel length was set 
equivalent to 100 µm. Total fiber number was estimated by dividing total cross sectional area of 
the ST by the average cross sectional area of individual muscle fibers. 
Gene Expression Analysis 
Total RNA was isolated from LD and PM muscles after tissue disruption using the Tri-
Reagent method (Sigma-Aldrich, St. Louis, MO) according to Clark et al. (2011). One µg of 
RNA was reverse transcribed into cDNA using qScript cDNA SuperMix (Quanta Biosciences, 
Gaithersburg, MD) according to manufacturer’s instructions. Then, cDNA was stored at -20° C 
until further analysis. 
Expression of ribosomal protein L19 (RPL 19) was unaffected by treatment, age and sex 
and therefore, was chosen as the reference gene. Quantitative real-time PCR was completed in 
accordance with qScript PerfeCTa FastMix II, Rox (Quanta Biosciences, Gaithersburg, MD) 
master mix procedures, using a Step One Plus qPCR machine (Applied Biosystems by Life 
Technologies; Grand Island, NY). Each gene of interest was normalized to RPL 19 expression 
and calibrated to the male control (calibrator group). The ΔΔCT method was used to calculate 
fold change between treatments and sexes. Expression of  TNF-α, IL-6, PRRSV, myostatin, 
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insulin-like growth factor 1 and 2, MYOD, MYF5, myogenin, PAX7, uncoupling protein 3, and 
the myosin heavy chain genes (Table 2.3) was quantified. All primers had efficiency between 90 
and 100%.   
Statistical analysis 
All data were analyzed using 2-way ANOVA in the MIXED procedure of SAS (Version 
9.3 SAS Institute Inc., Cary, NC, USA). The model included the fixed effects of treatment, sex, 
and their interactions. Piglet was the experimental unit for all data analysis. Treatment consisted 
of two groups: piglets born from control gilts (C) and, due to minimal differences and limited 
sample size, piglets born PRRSV positive and PRRSV negative data were pooled and analyzed 
as piglets born from PRRSV infected gilts (P). For gene expression data, ΔΔCt were analyzed 
and then displayed as fold changes standardized to male control piglets. Many piglets had TNF-
α, and IL-6 expression below detectable limits; therefore, in order to analyze these data 
categorical variables were assigned. All piglets with expression under detectable limits (CT > 40) 
were categorized as 0 (no expression) and others were split into tertiles with the least expression 
assigned a value of 1, mid-range expression assigned 2, and greatest expression assigned 3.  
These data were analyzed using a 2-way ANOVA in the GLIMMIX procedure of SAS. The 
model included the fixed effects of treatment, sex, and their interactions. All residuals were 
tested for normality using the Univariate procedure of SAS with normal probability plots. Least 
square means were separated with the PDIFF option. Statistical differences were accepted as 
significant at P<0.05 and trends were noted at 0.05<P<0.10.  
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RESULTS  
Effects of PRRSV Inoculation in Gilts 
 All gilts inoculated with PRRSV at day 80 of gestation tested positive for PRRSV 
infection one week after inoculation. Prior to infection, average daily feed intake was not 
different (P=0.47) between PRRSV inoculated gilts and control gilts (Figure 2.1). Average daily 
feed intake decreased (P=0.04) approximately 36% in PRRSV inoculated gilts compared with 
control gilts between 0 and 11 days after inoculation. From 11 days after inoculation until 
farrowing, average daily feed intake, however, was similar between treatments (P>0.21). Prior to 
infection, average daily body temperature was not different (P=0.80) between PRRSV inoculated 
gilts and control gilts. Average daily body temperature increased (P=0.04) approximately 0.5°C 
in PRRSV inoculated gilts compared with control gilts between 0 and 11 days after inoculation. 
From 11 days after inoculation until farrowing, average daily body temperatures were similar 
between treatments (P>0.21).  
Body and Muscle Weights of Offspring 
 At d0, there were no differences (P>0.17) in body weight, absolute muscle weights, and 
body length between treatment groups (Table 2.4). There tended to be an interaction between 
treatment and sex as LD weight tended to be reduced (P<0.09) in female P piglets compared with 
male P piglets and female C piglets, but LD weights were not different from male C piglets. 
Furthermore, there was an interaction between treatment and sex as PM weight was heavier 
(P<0.08) in male P piglets compared with all other treatments. Relative LD weight was reduced 
(P=0.01) and relative ST weight tended to be reduced (P=0.08) in P piglets compared with C 
piglets. Furthermore, there was an interaction between treatment and sex as relative PM weight 
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was increased (P<0.01) in male P piglets compared with all other treatment and sex 
combinations.  
 At d28, body weight tended to be decreased (P=0.07) in P piglets compared with C 
piglets, but there were no differences in body length between treatments. Whole LD (P=0.01) 
and relative LD (P=0.03) weights were reduced in P piglets compared with C piglets, but whole 
and relative weights of PM and ST muscles were not different (P>0.29) between treatment 
groups.  
Muscle Fiber Number and Area, and Inflammatory Cytokine Expression 
At d28, average fiber area within the ST was increased (P=0.02) by 30% in P piglets 
compared with C piglets (Figure 2.2). However, muscle cell number of the ST was reduced 
(P=0.04) by 33% in P piglets compared with C piglets.  
At d0 in the PM, there were no differences in IL-6 or TNF-α expression between P piglets 
and C piglets within muscle (Table 2.5). There was an interaction between treatment and sex as 
TNF-α expression increased (P<0.02) in LD of male P piglets compared with male C piglets, but 
expression did not differ between treatment in females (P=0.14). However, at d28, IL-6 (P<0.01) 
and TNF-α (P<0.01) expression in muscle tissue (LD and PM) were increased in P piglets 
compared with C piglets.  
Longissimus Dorsi – Gene Expression 
At d0, MHC2b (P=0.02) and MHC2x (P=0.01) expression was reduced in LD of P piglets 
compared with C piglets, but there were no differences (P<0.15) in MHC1 and MHC2a 
expression between treatments (Table 2.6). Myostatin expression decreased (P=0.01) in P piglets 
compared with C piglets. However, Myf5 expression, a myogenic regulatory factor, was also 
decreased (P=0.03) in P piglets compared with C piglets. There were no differences (P>0.11) in 
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MYOD, myogenin, IGF1, IGF2, or PAX7 expression between treatments, however, UCP3 
expression was increased (P=0.05) in P piglets compared with C piglets.  
At d28, MHC2a expression tended to decrease (P=0.08) in P piglets compared with C 
piglets (Table 2.7); however, there were no differences (P>0.44) in MHC 2b, or 2x expression. In 
addition, there was an interaction between treatment and sex as MHC1 expression increased 
(P<0.08) in female P piglets compared with male P piglets and C piglets. There were no 
differences (P>0.13) in positive or negative growth factors, except PAX7 expression was 
increased (P=0.02) in P piglets compared with C piglets.  
Psoas Major – Gene Expression 
At d0, MHC1 expression was increased (P=0.03) in PM of P piglets compared with C 
piglets; however there were no differences (P>0.18) in MHC2a, 2x, or 2b expression (Table 2.8). 
Myostatin and MYF5 expression decreased (P≤0.04) in P piglets compared with C piglets while 
MYOD, myogenin, and IGF2 expression were increased (P≤0.02). In addition, UCP3 expression 
was increased (P<0.01) in P piglets compared with C piglets. Additionally, there tended to be an 
interaction between treatment and sex as PAX7 expression was reduced (P<0.08) in female C 
piglets compared with all other treatment and sex combinations. At d28, there were no 
differences (P>0.11) in myosin heavy chain and myogenic growth factor expression in PM 
between treatments (Table 2.9). However, there was an interaction between treatment and sex as 
MYOD expression was reduced (P<0.02) in female C piglets compared with all other treatment 
and sex combinations.  
DISCUSSION 
Immunological stress or infection causes a disruption in homeostasis through production 
of inflammatory cytokines that direct nutrients away from muscle protein synthesis (Fredette and 
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Landmesser, 1991). However, the effect of and mechanisms by which maternal infection 
influences skeletal muscle development remain unclear. Thus, the objectives of this study were 
to determine how skeletal muscle growth was altered in offspring from gilts subjected to 
immunological stress through maternal PRRSV infection during pregnancy and understand the 
molecular mechanisms that regulate muscle growth as a result of maternal infection.  
Maternal infection caused a 33% reduction in ST muscles fiber number in P piglets 
compared with C piglets. Previous studies demonstrate reduction in muscle fiber number may 
have been due to maternal nutrient restriction (Zhu et al., 2006). In this study, however, the 
decrease in gilt feed intake due to PRRSV infection was both mild (36%) and transient (< 11 d). 
Therefore, while possible, it is unlikely that nutrient restriction alone explains the reduction in 
muscle fiber number. On the other hand, piglets from maternally over-fed sows had a reduction 
in muscle fiber number due to a decrease in secondary fiber population (Dwyer et al., 1994; 
Wigmore and Stickland, 1983). These over-fed sows also had increased inflammatory cytokines, 
IL-6 and TNF-α, similar to PRRSV infection (Black, 2003; Thanawongnuwech et al., 2004). 
Although inflammatory cytokine (TNF-α or IL-6) expression was not greater in fetal skeletal 
muscle of P piglets compared with C piglets, P piglets may have been exposed to increased 
circulating TNF-α or IL-6 or had increased expression in another tissue. Maternal inflammatory 
cytokines can pass directly to the fetus or they can stimulate the production of fetal inflammation 
cytokines (Ashdown et al., 2006; Fortunato et al., 1996; Urakubo et al., 2001). More importantly, 
in an equal nutrient intake trial, transgenic mice expressing increased levels of circulating 
inflammatory cytokines had a 50-70% decrease in weight compared with non-transgenic 
littermates suggesting decreases in growth was due to inflammatory cytokines (DeBenedetti et 
al., 1997). We, therefore, hypothesize maternal inflammatory cytokines reduced secondary fiber 
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populations.  Reductions in muscle fiber number correlate with reduced growth rates and 
ultimately, lighter weight pigs with decreased lean growth efficiency (Dwyer et al., 1993). 
Therefore, maternal infection may result in impaired muscle development, reduced growth 
efficiency, and decreased overall lean muscle yield of progeny.  
In our study, the effect of maternal PRRSV infection on muscle growth and gene 
expression differed between muscles. The PM was chosen as a representative slow, oxidative 
muscle; MHC type 1 is its predominant fiber type (Leseigneur-Meynier and Gandemer, 1991). 
Myosin type 2 fibers experience more hypertrophic growth than MHC type 1 fibers (Ashmore et 
al., 1973). Furthermore, in muscle atrophy studies, MHC type 2 fibers were more prone to 
reductions in muscle fiber area while little effect was observed in MHC type 1 fibers (Balagopal 
et al., 2001; Lexell et al., 1988). This suggests that MHC type 2 fibers are more sensitive to both 
hypertrophic and atrophic signals than type 1 fibers. Therefore, restriction in muscle growth due 
to maternal infection should be more prominent in muscles with a greater degree of MHC type 2 
fibers.  
In our study, this was, in fact, the case. At d0, PM and ST muscle weight were increased 
in P piglets compared to C piglets, and at d28, PM and ST weights were unaffected by maternal 
PRRSV infection. On the other hand, LD weight was reduced in P piglets compared with C 
piglets at both d0 and d28. This reduction in weight was accompanied by reduced MHC 2x and 
2b expression at d0, as well as reduced expression of the myogenic regulatory factor MYF5. 
Contrary to these findings was increased myostatin expression at d0 in LD muscle, which may 
suggest compensatory hypertrophy by the muscle to overcome a reduction in muscle fiber 
number.  
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Compensatory growth can be defined as a process by which an animal accelerates its 
growth after a period of restricted development (Hornick et al., 2000). Compensatory gain is also 
suggested in the PM and ST muscles. Increased hypertrophy of ST fibers was observed. 
Furthermore, myostatin expression was reduced and IGF2, MyoD, myogenin and PAX7 
expression were increased in PM muscles at d0 in P piglets compared with C piglets. Myostatin 
is known to be an inhibitor of muscle growth, therefore, a decrease in myostatin expression and 
elevated IGF2 expression can lead to protein synthesis and increase lean tissue deposition 
(Haidet et al., 2008; Lin et al., 2002; Whittemore et al., 2003). Furthermore, an increase in 
MYOD expression causes an increase in myoblasts and satellite cell activation, which leads to an 
increase in myogenin expression (Adams et al., 1999; Smith et al., 1994). Myogenin expression 
is associated with terminal differentiation, suggestion PM of P piglets was still undergoing 
muscle formation.  Moreover, an increase in PAX7 suggests the PM of P piglets had an increase 
in satellite cell population for further growth or regeneration of skeletal muscle (Olguin and 
Olwin, 2004). Due to the nature of PRRSV infected samples, data regarding fiber area of specific 
fiber types were unavailable, but such data may provide greater insight to this phenomenon.  
CONCLUSION 
Maternal PRRSV infection restricts in utero muscle fiber development as evidenced by 
the reduced muscle cell number. Increased IGF2 expression and decreased myostatin expression 
at d0 in the PM and increased muscle fiber size observed in the ST suggests compensatory 
muscle growth. Although large differences were not observed in muscle weights between 
treatments, we predict efficiency would be lost during the finishing phases of production as a 
decrease in muscle fiber number would likely lead to slower growing pigs. It is essential to know 
the infection status of a breeding herd as visual cues (decrease feed intake, increase body 
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temperature) may be subtle, but maternal infection during the prenatal period may limit muscle 
development and have long term effects on lean growth efficiency.  
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TABLES 
 
   
Table 2.1 Number of infected and non-infected gilts per set and age of 
piglets at the time of euthanization. 
Gilt Set Control PRRSV Inoculated Age of Piglets when Euthanized 
1 1 1 0 days 
2 0 2 0 days 
3 1 1 28 days 
4 1 1 28 days 
5 2 0 0 days 
37 
 
Table 2.2  Composition of diet fed to gilts1 
Ingredient % Diet 
Soybean Meal 11.55 
Dicalcium Phosphate 1.90 
Lime 0.75 
Corn 77.15 
Beet Pulp 7.00 
Choice White Grease 1.00 
Swine Trace Mineral Salt1 0.35 
Sow Pac2 0.10 
Vitmix ADEK3 0.20 
1Swine trace mineral salt included the following 
percentage per kilogram added: Salt, 80-85%; Iron, 
2.57%; Zinc, 2.86%; Manganese, 0.57%; Copper, 
0.23%; Iodine, 0.01%; Selenium, 0.01%. 
2Sow Pac included the following per kilogram 
added: Biotin, 221 mg; Choline; 661,387 mg; Folic 
Acid, 2,205 mg. 
3Vitmix ADEK included the following per kilogram 
added: Vitamin A (retinyl acetate), 3,306,937 IU; 
Vitamin D3 (cholecalciferol), 330,694 IU; Vitamin 
E (dl-α tocopheryl acetate), 44,093 IU; Vitamin K 
(menadione nicotinamide bisulfite), 2,205 mg; 
Riboflavin, 4,409 mg; Vitamin B12, 17.64 mg; d-
Pantothenic acid (d-calcium pantothenate), 12,125 
mg; Niacin (nicotinamide and nicotinic acid), 
16,535 mg; Choline, 143,190 mg.  
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Table 2.3 Taqman primers and probe sequences used for quantitative real-time PCR. 
Gene 
Symbol 
Gene Name 
Gene Bank 
Reference 
Sequence 
Forward Sequence 
Reverse Sequence 
Probe Sequence 
IGF11 
insulin-like 
growth factor 1  
NM_214256.1 
 
IGF22 
insulin-like 
growth factor 2 
NM_213883.2 
CCGTGCTTCCGGACAACT 
AGGTGTCATAGCGGAAGAACTTG 
CCCCAGATACCCCGTGG 
IL-62 interleukin-6 NM_001252429.1 
AACAACCTGAACCTTCCAAAAAT 
TCCACAAGACCGGTGGTGAT 
CAATCAGGAGACCTGCT 
MHC12 
myosin heavy 
chain 1 
NM_001104951.1 
AATGTCCAGCAGGTGATGTATGC 
ATCCGTGTCACCATCCAGTTG 
AGGCCGTGTATGAGAAG 
MHC2a2 
myosin heavy 
chain 2a 
NM_214136.1 
GCAAAAGCGTAATGCTGAAGCT 
CCTCTTCCGTCTGGTAGGTGAGT 
TGCGCAAACATGAGAGG 
MHC2b2 
myosin heavy 
chain 2b 
NM_001123141.1 
GGGTCTTCGGAAACATGAGAGA 
TCCTGCAGCCTGAGAACATTC 
TTACCAGACTGAGGAGGAC 
MHC2x2 
myosin heavy 
chain 2x 
NM_001104951.1 
GGGTCTACGCAAACACGAGAGA 
CAGATCCTGGAGCCTGAGAATG 
AAGGAACTCACTTACCAAAC 
MYF52 
myogenic factor 
5 
NM_001278775.1 
GTCCAGAAAGAGCAGCAGTTTTG 
AGGAGCTTTTATCCGTGGCATAT 
ATCTACTGTCCGGATGTAC 
MYOD1 
myogenic 
differentiation 1 
NM_001002824.1 
 
Myogenin2 Myogenin NM_001012406.1 
GTCCAGAAAGAGCAGCAGTTTTG 
AGGAGCTTTTATCCGTGGCATAT 
ATCTACTGTCCGGATGTAC 
Myostatin2 Myostatin NM_214435.2 
CGACGGAAACGATCATTACCA 
AAGCAGCATTTGGGTTTTCCT 
TACAGAGTCTGATCTTCTAATG 
PAX72 paired box 7 XM_005659088.1 
AGGCAGCAAGCCCAGACA 
CCCTCTTGTACTCCTCAATCTTTTTC 
CGACTCCGGATGTGG 
PRRSV2 PRRSV AY150312 
CGCACCAGATGGGACCTACTT 
ACGGTGTTCAGTGAGGGCTTT 
CGCTGCGTTGACTGG 
RPL 192 
ribosomal protein 
L19 
XM_003131509.3 
TGACCGCCACATGTATCACAGT 
TGTGGATGTGCTCCATGAGAA 
TGTACCTGAAAGTGAAGGG 
TNF-α2 
tumor necrosis 
factor 
NM_214022.1 
TGACCGCCACATGTATCACAGT 
TGTGGATGTGCTCCATGAGAA 
TGTACCTGAAAGTGAAGGG 
UCP31 
uncoupling 
protein 3  
NM_214049.1 
 
1 ABI Assay ID: IGF1 = Ss03394499_m1, MYOD = Ss03378464_u1, UCP3 = 
Ss03391403_m1 
2Custom design assay ID
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Table 2.4 Effects of maternal porcine reproductive and respiratory virus (PRRSV) inoculation on offspring body weight, length, and 
muscle weights at birth. 
 Treatment Sex  P-Values 
Item Control PRRSV Male Female SEM1 T S T X S2 
Day 0         
Piglets, n 34 25 35 24     
Body Weight, kg 1.27 1.23 1.29 1.20 0.07 0.65 0.35 0.11 
Body Length, cm 25.68 27.08 26.11 26.64 0.79 0.17 0.59 0.13 
Longissimus Dorsi, g 13.46 12.15 13.37 12.24 0.98 0.30 0.37 0.08 
Relative weight3 1.09 0.96 1.04 1.01 0.03 0.01 0.56 0.20 
Psoas Major, g 2.58 3.00 2.98 2.60 0.25 0.19 0.24 0.01 
Relative weight3 0.20 0.24 0.23 0.22 0.01 0.01 0.44 <0.01 
Semitendinosus, g 2.41 2.67 2.73 2.34 0.23 0.37 0.19 0.20 
Relative weight3 0.19 0.22 0.21 0.20 0.01 0.08 0.43 0.51 
Day 28 
Piglets, n 12 12 15 9     
Body Weight, kg 5.30 4.87 5.08 5.09 0.08 0.07 0.97 0.85 
Body Length, cm 42.27 40.72 40.92 42.06 1.17 0.19 0.33 0.98 
Longissimus Dorsi, g 87.75 73.23 72.59 87.75 5.11 0.01 0.14 0.50 
Relative weight3 1.66 1.50 1.51 1.65 0.05 0.03 0.06 0.51 
Psoas Major, g 16.15 13.55 15.08 14.62 1.40 0.11 0.82 0.71 
Relative weight3 0.30 0.28 0.29 0.30 0.01 0.29 0.67 0.57 
Semitendinosus, g 18.10 15.98 16.63 17.45 1.76 0.38 0.38 0.69 
Relative weight3 0.34 0.35 0.33 0.36 0.01 0.71 0.19 0.70 
1 SEM reported as maximum standard error of mean. 
2Trt = treatment, T X S = interaction between treatment and sex. 
3Muscle weight as a percentage of body weight. 
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Table 2.5 Effect of maternal porcine reproductive and respiratory virus (PRRSV) inoculation on offspring PRRSV and 
inflammatory cytokine status in muscle.1 
 Treatment Sex P-value 
Item2 Control PRRSV Male Female T S TxS 
Longissimus Dorsi           
Day 0            
IL-6 0.87 (0.75-0.98) 0.94 (0.80-1.07) 0.97 (0.85-1.08) 0.84 (0.70-0.98) 0.44 0.15 0.15 
TNF-α 1.10 (0.95-1.24) 1.22 (1.05-1.40) 1.21 (1.07-1.36) 1.11 (0.94-1.28) 0.26 0.36 0.01 
Day 28            
IL-6 1.06 (0.83-1.30) 1.52 (1.30-1.75) 1.32 (1.12-1.52) 1.26 (1.00-1.52) 0.01 0.71 0.26 
TNF-α 1.06 (0.87-1.24) 1.45 (1.28-1.63) 1.20 (1.04-1.36) 1.31 (1.11-1.51) <0.01 0.37 0.99 
Psoas Major            
Day 0            
IL-6 1.13 (0.98-1.28) 1.25 (1.07-1.43) 1.03 (0.98-1.29) 1.23 (1.07-1.43) 0.29 0.34 0.22 
TNF-α 0.88 (0.76-1.01) 0.86 (0.71-1.01) 0.78 (0.66-0.90) 0.96 (0.81-1.11) 0.80 0.07 0.58 
Day 28            
IL-6 1.06 (0.89-1.23) 1.49 (1.32-1.65) 1.23 (1.09-1.37) 1.31 (1.13-1.50) <0.01 0.48 0.79 
TNF-α 1.15 (0.96-1.33) 1.78 (1.61-1.96) 1.34 (1.19-1.49) 1.59 (1.39-1.79) <0.01 0.05 0.71 
1Values are least squares means of fold changes with 95% confidence intervals in parentheses. All values of gene 
expression were compared to that of male control pigs.  
2IL-6 = interleukin-6, TNF-α = tumor necrosis factor, T = treatment, S = sex, T X S = interaction between treatment and 
sex 
 
  
41 
 
Table 2.6 Effect of maternal porcine reproductive and respiratory virus (PRRSV) inoculation on offspring myosin 
heavy chain and myogenic growth factors gene expression in the longissimus dorsi at birth.1 
 Treatment Sex P-value 
Item2 Control PRRSV Male Female T S TxS 
MHC1 1.03 (0.40-2.66) 1.38 (0.57-3.31) 1.20 (0.46-3.13) 1.19 (0.50-2.83) 0.15 0.96 0.71 
MHC2a 1.04 (0.77-1.40) 0.89 (0.62-1.26) 0.93 (0.69-1.25) 0.99 (0.69-1.41) 0.48 0.79 0.93 
MHC2x 0.93 (0.63-1.38) 0.51 (0.34-0.75) 0.79 (0.53-1.19) 0.60 (0.40-0.90) 0.01 0.21 0.55 
MHC2b 0.74 (0.38-1.42) 0.36 (0.19-0.68) 0.75 (0.38-1.48) 0.35 (0.18-0.67) 0.02 0.02 0.62 
MYF5 0.95 (0.80-1.13) 0.71 (0.58-0.87) 0.85 (0.72-1.00) 0.79 (0.64-0.97) 0.03 0.58 0.84 
MYOD 0.78 (0.35-1.74) 1.26 (0.59-2.67) 1.36 (0.60-3.11) 0.72 (0.33-1.53) 0.11 0.03 0.62 
Myogenin 1.11 (0.73-1.68) 1.71 (1.02-2.86) 1.44 (0.97-2.15) 1.31 (0.78-2.22) 0.19 0.77 0.37 
Myostatin 0.93 (0.79-1.10) 0.65 (0.53-0.79) 0.86 (0.73-1.00) 0.71 (0.58-0.86) 0.01 0.14 0.69 
IGF1 0.87 (0.43-1.76) 0.64 (0.33-1.25) 0.85 (0.41-1.75) 0.66 (0.34-1.28) 0.25 0.35 0.93 
IGF2 0.91 (0.19-4.33) 0.95 (0.21-4.18) 0.96 (0.20-4.62) 0.90 (0.21-3.91) 0.87 0.80 0.61 
PAX7 0.95 (0.35-2.61) 0.89 (0.33-2.38) 1.00 (0.36-2.76) 0.85 (0.32-2.24) 0.59 0.18 0.62 
UCP3 0.68 (0.46-1.00) 1.26 (0.80-2.00) 1.17 (0.81-1.70) 0.73 (0.46-1.18) 0.05 0.13 0.32 
1Values are least squares means of fold changes with 95% confidence intervals in parentheses. All values of gene expression 
were compared to that of male control pigs. 
2 MHC = Myosin Heavy Chain, MYF5 = Myogenic factor 5, MYOD = myogenic differentiation 1, IGF1 = insulin-like 
growth factor 1, IGF2 = insulin-like growth factor 2, PAX7 = paired box 7, UCP3 = uncoupling protein 3, T = treatment, S = 
sex, T X S = interaction between treatment and sex. 
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 Table 2.7 Effect of maternal porcine reproductive and respiratory virus (PRRSV) inoculation on offspring myosin 
heavy chain and myogenic growth factors expression in the longissimus dorsi at 28 days of age.1 
 Treatment Sex P-value 
Item2 Control PRRSV Male Female T S TxS 
MHC1 1.00 (0.77-1.29) 1.13 (0.91-1.42) 0.89 (0.73-1.08) 1.28 (0.96-1.69) 0.44 0.04 0.04 
MHC2a 0.95 (0.59-0.95) 0.70 (0.41-1.17) 0.91 (0.44-1.88) 0.73 (0.45-1.17) 0.08 0.24 0.52 
MHC2x 1.17 (0.28-4.95) 1.29 (0.27-6.06) 1.10 (0.17-7.25) 1.38 (0.40-4.77) 0.59 0.22 0.63 
MHC2b 0.94 (0.51-1.75) 0.77 (0.43-1.40) 1.11 (0.66-1.88) 0.65 (0.33-1.29) 0.63 0.21 0.33 
MYF5 1.02 (0.85-1.23) 0.97 (0.80-1.16) 1.03 (0.88-1.22) 0.95 (0.78-1.17) 0.67 0.54 0.36 
MYOD 1.17 (0.88-1.54) 1.27 (0.98-1.66) 1.06 (0.84-1.34) 1.40 (1.03-1.90) 0.64 0.15 0.87 
Myogenin 0.82 (0.09-7.47) 0.69 (0.06-7.45) 0.83 (0.04-15.97) 0.68 (0.10-4.54) 0.56 0.51 0.56 
Myostatin 1.32 (0.80-2.19) 1.81 (0.53-1.59) 1.81 (1.18-2.78) 1.32 (0.75-2.34) 0.80 0.84 0.36 
IGF1 1.13 (0.43-2.94) 1.64 (0.58-4.66) 1.22 (0.30-4.99) 1.52 (0.63-3.64) 0.13 0.42 0.92 
IGF2 1.07 (0.90-1.28) 1.15 (0.97-1.37) 1.00 (0.86-1.16) 1.24 (1.02-1.51) 0.54 0.08 0.51 
PAX7 0.98 (0.86-1.12) 1.23 (1.09-1.41) 1.05 (0.33-3.36) 1.15 (0.52-2.52) 0.02 0.28 0.14 
UCP3 1.00 (0.57-1.74) 0.92 (0.53-1.59) 0.83 (0.51-1.37) 1.09 (0.59-2.02) 0.83 0.48 0.47 
1Values are least squares means of fold changes with 95% confidence intervals in parentheses. All values of gene expression 
were compared to that of male control pigs. 
2 MHC = Myosin Heavy Chain, MYF5 = Myogenic factor 5, MYOD = myogenic differentiation 1, IGF1 = insulin-like 
growth factor 1, IGF2 = insulin-like growth factor 2, PAX7 = paired box 7, UCP3 = uncoupling protein 3, T = treatment, S = 
sex, T X S = interaction between treatment and sex. 
  
43 
 
Table 2.8 Effect of maternal porcine reproductive and respiratory virus (PRRSV) inoculation on offspring myosin 
heavy chain and myogenic growth factors gene expression in the psoas major at birth.1 
 Treatment Sex P-value 
Item2 Control PRRSV Male Female T S TxS 
MHC1 0.98 (0.78-1.24) 1.47 (1.11-195) 1.16 (0.93-1.46) 1.24 (0.93-1.65) 0.03 0.72 0.59 
MHC2a 0.90 (0.63-1.30) 0.98 (0.71-1.37) 0.98 (0.68-1.41) 0.91 (0.66-1.27) 0.42 0.52 0.23 
MHC2x 0.78 (0.54-1.13) 0.70 (0.49-0.98) 0.83 (0.57-1.21) 0.65 (0.46-0.93) 0.42 0.11 0.11 
MHC2b 1.18 (0.25-5.64) 1.61 (0.37-6.97) 1.18 (0.25-5.62) 1.62 (0.38-6.96) 0.18 0.17 0.94 
MYF5 0.97 (0.84-1.12) 0.73 (0.62-0.88) 0.86 (0.74-0.99) 0.83 (0.69-0.99) 0.02 0.79 0.77 
MYOD 0.87 (0.62-1.22) 1.77 (1.27-2.48) 1.28 (0.90-1.82) 1.20 (0.85-1.68) <0.01 0.69 0.23 
Myogenin 0.95 (0.68-1.31) 1.57 (1.13-2.18) 1.21 (0.87-1.70) 1.23 (0.88-1.71) <0.01 0.95 0.49 
Myostatin 0.97 (0.81-1.15) 0.73 (0.59-0.90) 0.92 (0.77-1.08) 0.77 (0.62-0.95) 0.04 0.19 0.42 
IGF1 0.99 (0.85-1.15) 0.90 (0.74-1.09) 0.98 (0.85-1.14) 0.90 (0.74-1.10) 0.44 0.48 0.60 
IGF2 1.03 (1.24-1.83) 1.50 (0.87-1.21) 1.11 (0.94-1.30) 1.40 (1.14-1.70) <0.01 0.07 0.16 
PAX7 0.85 (0.69-1.03) 1.14 (0.93-1.41) 1.03 (0.84-1.27) 0.94 (0.76-1.16) 0.02 0.46 0.08 
UCP3 0.84 (0.43-1.67) 2.89 (1.52-5.50) 1.61 (0.81-3.24) 1.51 (0.79-2.87) <0.01 0.78 0.32 
1Values are least squares means of fold changes with 95% confidence intervals in parentheses. All values of gene expression 
were compared to that of male control pigs. 
2 MHC = Myosin Heavy Chain, MYF5 = Myogenic factor 5, MYOD = myogenic differentiation 1, IGF1 = insulin-like 
growth factor 1, IGF2 = insulin-like growth factor 2, PAX7 = paired box 7, UCP3 = uncoupling protein 3, T = treatment, S = 
sex, T X S = interaction between treatment and sex. 
  
44 
 
Table 2.9 Effect of maternal porcine reproductive and respiratory virus (PRRSV) inoculation on offspring myosin 
heavy chain and myogenic growth factors expression in the psoas major at 28 days of age.1 
 Treatment Sex P-value 
Item2 Control PRRSV Male Female T S TxS 
MHC1 0.94 (0.59-1.50) 0.83 (0.52-1.34) 1.02 (0.69-1.51) 0.77 (0.45-1.32) 0.71 0.40 0.64 
MHC2a 0.93 (0.67-1.29) 0.98 (0.72-1.33) 1.07 (0.81-1.41) 0.84 (0.60-1.20) 0.83 0.29 0.68 
MHC2x 0.93 (0.13-6.89) 0.76 (0.09-6.29) 0.86 (0.08-9.55) 0.82 (0.14-4.77) 0.18 0.68 0.56 
MHC2b 0.77 (0.16-3.73) 0.48 (0.07-3.21) 0.79 (0.05-12.58) 0.47 (0.09-2.50) 0.40 0.43 0.99 
MYF5 1.04 (0.77-1.40) 0.85 (0.85-1.13) 0.86 (0.67-1.11) 1.02 (0.74-1.41) 0.32 0.39 0.64 
MYOD 0.59 (0.42-0.83) 0.66 (0.48-0.89) 0.79 (0.60-1.05) 0.49 (0.34-0.71) 0.63 0.04 0.02 
Myogenin 1.00 (0.78-1.28) 0.76 (0.60-0.96) 0.82 (0.66-1.01) 0.93 (0.70-1.22) 0.11 0.46 0.45 
Myostatin 0.71 (0.18-2.88) 0.74 (0.09-6.09) 0.96 (0.07-12.83) 0.55 (0.15-2.06) 0.51 0.03 0.74 
IGF1 0.89 (0.33-2.43) 0.70 (0.24-2.05) 0.87 (0.24-3.13) 0.72 (0.27-1.90) 0.45 0.56 0.91 
IGF2 0.97 (0.48-1.93) 0.94 (0.44-1.98) 1.01 (0.39-2.63) 0.90 (0.49-1.63) 0.78 0.33 0.68 
PAX7 0.79 (0.59-1.07) 0.72 (0.56-0.94) 0.82 (0.65-1.03) 0.70 (0.51-0.97) 0.64 0.41 0.12 
UCP3 0.88 (0.36-2.13) 1.03 (0.46-2.28) 1.33 (0.35-5.11) 0.68 (0.28-1.63) 0.52 0.04 0.22 
1Values are least squares means of fold changes with 95% confidence intervals in parentheses. All values of gene expression 
were compared to that of male control pigs. 
2 MHC = Myosin Heavy Chain, MYF5 = Myogenic factor 5, MYOD = myogenic differentiation 1, IGF1 = insulin-like 
growth factor 1, IGF2 = insulin-like growth factor 2, PAX7 = paired box 7, UCP3 = uncoupling protein 3, T = treatment, S = 
sex, T X S = interaction between treatment and sex.
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Figure 2.1 Effects of PRRSV inoculation on feed intake (A) and body temperature (B) of gilts. 
** represent values that are significantly different at P<0.05. Each value is the mean and the bars 
represent the standard error of the mean. DAI = days after inoculation, ADFI = average daily 
feed intake, ADT = average daily temperature. 
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Figure 2.2 Muscle cell number and fiber area of the semitendinosus in 28 d old piglets from 
control and PPRSV infected gilts from PRRSV inoculated gilts. ** represent values that are 
significantly different at α=0.05. Each value is the mean and the bars represent the standard error 
of the mean. 
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CHAPTER 3 
EFFECTS OF POSTNATAL INFECTION WITH PORCINE REPRODUCTIVE 
AND RESPIRATORY SYNDROME VIRUS ON MUSCLE GROWTH AND GENE 
EXPRESSION IN PIGS 
ABSTRACT  
In swine, viral infections decrease growth in part by directing nutrients away from skeletal 
muscle; however, the effect of viral infections on myogenic factors that regulate muscle 
hypertrophy are not clearly defined. Therefore, the objective of this study was to delineate 
alterations in gene expression profiles that govern muscle growth in response to porcine 
reproductive and respiratory syndrome virus (PRRSV) during a rapid growth period. Differential 
responses dependent on fiber type were also investigated. Pigs were inoculated with PRRSV or 
sterile culture medium (control) at 35 days of age, maintained on similar diets and euthanized 14 
days after inoculation. Upon sacrifice, body weight and weights of longissimus dorsi (LD), psoas 
major (PM) and semitendinosus (ST) muscles were assessed. Samples from the LD (fast 
glycolytic muscle) and PM (slow oxidative muscle) were used for gene expression, while the ST 
was used to determine muscle fiber cross sectional area and number. From 0 to 14 days after 
inoculation, body weight (P<0.01) and feed intake (P<0.04) were reduced 27% and 37%, 
respectively, in PRRSV-inoculated pigs compared with control pigs. Longissimus dorsi, ST, and 
PM weights were reduced (P<0.01) in pigs inoculated with PRRSV compared with control pigs. 
In addition, muscle fiber size of PRRSV-inoculated pigs tended to be reduced (P=0.09) 
compared with control pigs, but muscle cell number was unaffected. In the PM, myostatin 
expression tended to be increased (P=0.08) while MYF5 (P=0.01) and insulin-like growth factor 
1 (P=0.04) were decreased in pigs inoculated with PRRSV compared with control pigs. Also in 
the PM, myosin heavy chain (MHC) 2b and 2x decreased (P<0.01) in pigs inoculated with 
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PRRSV compared with control pigs, suggesting a reduction in muscle hypertrophy. In the LD, 
myogenic differentiation factor 1 (MYOD) was increased (P<0.01) and IGF 2 was decreased 
(P=0.04) but there were no differences (P > 0.22) in MHC expression in pigs inoculated with 
PRRSV compared with control pigs. Overall, PRRSV infection decreased muscle weights and 
cell size through a decrease in muscle hypertrophy. However, gene expression differences 
between LD and PM muscles suggest muscles with opposing fiber types may respond differently 
to PRRSV infection.  
Key words: 
 Muscle, Infection, Immunological Stress, Porcine Reproductive and Respiratory 
Syndrome Virus 
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INTRODUCTION 
An immunological stress response can be defined as a shift in nutrient partitioning away from 
tissue growth and towards the immune system in an effort to reach homeostasis following 
infection (Klasing and Johnstone, 1991). Although this immunological stress response is 
beneficial to the survival and recovery of the host, this response results in undesirable effects on 
the growth and production performance of the animal. Immunological stress elicits an 
inflammatory response through the production of inflammatory cytokines, including interlukin-6 
(IL-6) and tumor necrosis factor alpha (TNF-α), to inhibit the spread of a virus (Black, 2003). 
However, IL-6 and TNF-α inhibit muscle cell proliferation and differentiation partially through 
increased expression of myostatin (Roubenoff, 2007) thereby reducing the capacity for muscle 
growth (Zhu et al., 2004). 
Furthermore, muscles are comprised of different fiber types that can be classified by their 
metabolic properties among other biochemical and physiological characteristics. Inflammatory 
cytokines alter tissue metabolism through energy redistribution (Wisse, 2004), by decreasing 
protein synthesis and increasing catabolism (Wellen and Hotamisligil, 2005). Inflammation is 
also a potential mechanism of sarcopenia, or age related loss of muscle mass. Sarcopenia targets 
a reduction in MHC 2 fiber number and size with minimal changes in MHC 1 fibers 
(Deschenes, 2004). Therefore, fiber type composition may be a determinant of which fibers are 
targeted to obtain nutrients required to fight infection during an immunological stress response. 
A more thorough understanding of how immunological stress affects the molecular mechanisms 
that reduce growth is needed to determine if nutritional programs can prevent growth restriction. 
The objectives of this study were to delineate how the molecular mechanisms that govern 
muscle growth are altered in pigs infected with porcine reproductive and respiratory syndrome 
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virus (PRRSV) during a rapid growth period, and to determine how muscles comprised of 
different fiber types differ in their response to infection.  
MATERIALS AND METHODS 
Animal Procedures 
All animal procedures were approved by the Institutional Animal Care and Use 
Committee of University of Illinois and followed guidelines recommended in the Guide for the 
Care and Use of Agricultural Animals in Agricultural Research and Teaching (FASS, 2010). 
Sixteen castrated male weanling pigs from the University of Illinois Swine Research Center were 
delivered to the Edward R. Madigan Laboratory at 21 days of age. When received, each pig was 
housed individually in a disease containment chamber and received three intramuscular 
injections of lincomycin (11 mg/kg of body weight; Zoetis, Florham Park, NJ) for preventative 
care. To acclimate to the facility, pigs were fed a common diet that met or exceeded the 
Nutritional Research Council (2012) nutrient requirements and had ab libitum access to feed and 
water for one week. At 28 days of age, pigs were weighed and divided into 2 uniform groups 
based on body weight and litter of origin. Once divided, both groups were fed a diet (Table 3.1) 
that contained 17.5% soybean meal. Pigs were given a one week adaptation period to the diet 
prior to inoculation. Feed intake was recorded daily by weighing remaining feed in the feeder 
from the previous day. Body weight was also recorded daily and subtracted from pig weight at 
28 days of age to calculate body weight gain. 
At 35 days of age, one group (n=8) was intranasally inoculated with a 1 × 105 50% tissue 
culture infective dose of PRRSV (P-129 isolate, Purdue University, West Lafayette, IN) diluted 
in 2 mL of Dulbecco’s phosphate buffered saline (PBS) while the control group (n=8) received 2 
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mL of Dulbecco’s PBS intranasally. To avoid cross-contamination, PRRSV infected pigs were 
housed in a separate hall from controls. At 14 days after inoculation, pigs were anesthetized by 
intramuscular injection of TKX (mixture of Telazol®, ketamine, and xylazine; 4.4 mg/kg BW, 
Fort Dodge Animal Health, Fort Dodge, IA) and euthanized by intracardiac administration of a 
lethal dose of sodium pentobarbital (390 mg/ml Fatal Plus - administered at 1 ml/5 kg BW, 
Vortech Pharmaceuticals, Dearborn, MI). Serum PRRSV load was measured at 0, 3, 7, and 14 
days after inoculation by extracting PRRSV RNA and analyzing with real-time PCR (University 
of Illinois Veterinary Diagnostic Laboratory, Urbana, IL). Viral load was expressed as cycle 
threshold (Ct) values, where a higher Ct value represents a lower amount of PRRSV RNA. 
Growth Measurements and Sampling 
 At sacrifice, body weight and crown-to-rump length was recorded for each piglet. The 
semitendinosus (ST), longissimus dorsi (LD), and psoas major (PM) were removed from the left 
side of each piglet and weighed. Three samples (100mg) were collected from the LD and PM, 
placed in RNAlater (Ambion-Life Technologies, Grand Island, NY) and held at -80˚C until gene 
expression analysis. Samples of the LD were collected posterior to the spinalis dorsi. Ten mL 
blood samples were also collected for TNF-α detection by ELISA. 
Muscle cell number and size 
To determine muscle cell number and size, the ST from each piglet was anchored by 
string to a wooden stick to prevent shortening and held at 4˚C until rigor mortis was complete 
(approximately 24 hours). After 24 hours, the ST was submerged in approximately 8 mL of 10% 
neutralized buffered formalin (37% formaldehyde, Fischer Scientific, Fair Lawn, New Jersey). 
After 48 hours of submersion, the ST was sliced in half, perpendicular to the direction of the 
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muscle fibers, and the cut face of the ST was traced on acetate paper. To determine the cross 
sectional area of the muscle, outlines were traced using an Intuos 4 Wacom tablet (PTK-840; 
Tokyo, Japan) into Adobe Photoshop CS5 Extended (Adobe Systems Incorporated, San Jose, 
CA) and measured. Next, approximately 1 cm3 samples were collected from each ST to 
determine cross sectional area and muscle fiber number. Using these samples, approximately 3 
7-μm sections per animal were cut perpendicular to the muscle fibers with a microtome, fixed to 
a glass slide and stained with hematoxylin and eosin. Five random images were captured for each 
section using a total magnification of 564X on an AMG Exos XL Microscope (EVOS, Bothell, 
WA). The area of all fibers in each of five images were measured using Adobe Photoshop CS5 
Extended (Adobe Systems Incorporated, San Jose, CA) to determine an average cross sectional 
area of individual muscle fibers. Images were standardized to a 100 µm scale bar where 440 
pixel length was set equivalent to 100 µm. Total fiber number was then estimated by dividing 
total cross sectional area of the ST by the average cross sectional area of individual muscle 
fibers. 
Gene Expression Analysis 
Total RNA was isolated from LD and PM muscles after tissue disruption using the Tri-
Reagent method (Sigma-Aldrich, St. Louis, MO) according to Clark et al. (2011). One µg of 
RNA was reverse transcribed into cDNA using qScript cDNA SuperMix (Quanta Biosciences, 
Gaithersburg, MD) according to manufacturer’s instructions. cDNA was then stored at -20° C for 
further analysis. 
Expression of ribosomal protein L19 (RPL 19) was unaffected by treatment and 
therefore, was chosen as the reference gene. Quantitative real-time PCR was completed in 
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accordance with qScript PerfeCTa FastMix II, Rox (Quanta Biosciences, Gaithersburg, MD) 
master mix procedures, using a Step One Plus qPCR machine (Applied Biosystems by Life 
Technologies; Grand Island, NY). Each gene of interest was normalized to RPL 19 expression 
and then calibrated to the control pigs (calibrator group). The ΔΔCT method was used to 
calculate fold change between treatments. Expression of myostatin, insulin-like growth factor 1 
and 2, MYOD, MYF5, myogenin, PAX7, and the myosin heavy chain genes (Table 2.3) was 
quantified. All primers had efficiency between 90 and 100%.   
Statistical analysis 
Data were analyzed using a one way ANOVA in the MIXED procedure of SAS (Version 
9.3 SAS Institute Inc., Cary, NC, USA). Pigs was the experimental unit for all data analyses, and 
the model included fixed effect of treatment. Feed intake and body weight gain were analyzed as 
average weekly measurements. For gene expression data, ΔΔCT were analyzed and presented as 
fold change. All residuals were assessed for normality using normal probability plots with the 
Univariate procedure of SAS. Least square means were separated with the PDIFF option. 
Statistical differences were accepted as significant at P<0.05 and trends were noted as 
0.05<P<0.10.  
RESULTS 
PRRSV Inoculation 
 All pigs inoculated with PRRSV demonstrated clinical signs of infection as body weight 
(P<0.01) and feed intake (P=0.04) were reduced from d 0 to 7 after inoculation in pigs inoculated 
with PRRSV compared with control pigs (Figure 3.1 and Table 3.3). In the second week 
following inoculation, body weight (P<0.01), feed intake (P<0.01) and gain to feed (P<0.01) 
were reduced 27%, 37%, and 49% respectively, in pigs inoculated with PRRSV compared with 
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control pigs; however, gain to feed ratio was unaffected by PRRSV infection from 7 to 14 days 
after inoculation. Furthermore, serum TNF-α expression was increased (P<0.01) in PRRSV-
inoculated pigs compared with control pigs 3 days after inoculation, and remained elevated 
(P<0.01) until 14 days after inoculation (Figure 3.1).  
Muscle Weight, Cell Size and Number 
 Body length, LD, PM and ST weights were reduced (P<0.01) 11.6%, 34.9%, 54.6% and 
40.5%, respectively, in pigs inoculated with PRRSV compared with control pigs (Table 3.4). 
Relative PM and ST weights expressed as a percentage of body weight of PRRSV infected pigs 
were reduced (P<0.03) 16 and 7 percentage units, respectively, compared with control pigs.  
Muscle fiber number within the ST was not different (P = 0.99) between PRRSV-
inoculated and control pigs. However, cross sectional area of the muscle fibers tended to 
decrease (P=0.09) approximately 25% in PRRSV-inoculated pigs (571.0 ± 67.47 µm²) compared 
with control pigs (747.7 ± 67.47 µm²; Figure 3.2).  
Gene Expression 
In the LD, there were no differences in moystatin or myosin heavy chain expression 
between pigs in either treatment group (Table 3.5). However, IGF 2 expression (P=0.04) was 
decreased in pigs inoculated with PRRSV compared with control pigs. Conversely, MYOD 
(P<0.01) and myogenin (P=0.05) expression were increased in pigs inoculated with PRRSV 
compared with control pigs. Expression of all other positive growth factors (MYF5, IGF1, and 
PAX7) in the LD was unaffected by PRRSV infection. 
In the PM, MHC2b (P=0.01) and 2x (P<0.01) expression were decreased in pigs 
inoculated with PRRSV compared with control pigs, while MHC1 and 2a were unaffected by 
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PRRSV inoculation (Table 3.6). Furthermore, MYF5 (P=0.01) and IGF1 (P=0.04) expression 
was decreased as myostatin expression tended to increase (P=0.08) in pigs inoculated with 
PRRSV compared with control pigs. There were no differences in MYOD, myogenin, IGF2, and 
PAX7 expression between treatments.   
DISCUSSION 
In the United States, annual loss of productivity due to PRRSV was estimated at $664 
million (Zimmerman et al., 2012) mainly due to loss in production efficiency as immunological 
stress response reduces lean tissue growth (Sandberg et al., 2006). Defining mechanisms 
involved in inhibiting skeletal muscle protein accretion during infection is necessary to mitigate 
effects of the disease. The objectives of this study were to determine 1) measure gene expression 
that inhibit protein accretion in pigs infected with PRRSV during a rapid growth period, and 2) 
differential effects of PRRSV on skeletal muscle growth based on fiber type composition.     
Reductions in muscle weight due to postnatal PRRSV infection are assumed to be 
primarily the result of limited hypertrophy. This was confirmed in our study as PRRSV infection 
decreased muscle through a reduction in muscle fiber size in PRRSV-inoculated pigs compared 
with control pigs. PRRSV infection also elevated serum TNF-α and decreased IGF 2 expression 
in the LD and IGF 1 expression in the PM, reducing LD and PM muscle weights. These findings 
suggest that PRRSV infection restricts muscle growth by stimulating protein degradation, 
decreasing protein synthesis or a combination of both. Implicated in these processes are 
inflammatory cytokines, such as TNF-α and IL-6, which activate nuclear factor- κβ (NF- κβ) 
causing protein degradation through the ubiquitin pathway (Grounds et al., 2008). Increased 
circulating TNF-α concentrations in PRRSV infected pigs of our study is suggestive of increased 
muscle protein degradation.  Additionally, increased circulating inflammatory cytokines may 
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also decrease circulating IGF1 concentrations and reduce overall body weight (DeBenedetti et 
al., 1997). Decreased muscle IGF expression is associated with increased muscle atrophy and 
decreased muscle protein synthesis (Grounds et al., 2008). 
Another possible mechanism limiting hypertrophy in PRRSV-infected pigs is myostatin, 
which was increased in PM in our study. Myostatin was previously implicated in the inhibition 
of muscle growth during PRRSV infection (Escobar et al., 2004). Myostatin is a known negative 
regulator of myoblast proliferation and skeletal muscle growth, and is thought to reduce growth 
in part by inhibiting the mammalian target of rapamycin (mTOR) signaling pathway 
(Trendelenburg et al., 2009). Reduced mTOR activity decreases myoblast differentiation through a 
decrease in myogenic regulatory factors (Haidet et al., 2008; Lin et al., 2002; Whittemore et al., 
2003). Therefore, increased myostatin may be responsible for reduced MYF5 expression in pigs 
inoculated with PRRSV compared with control pigs in the PM. Furthermore, myogenic 
regulatory factors act as transcription factors for several muscle specific genes including the 
myosin heavy chains (Noden et al., 1999). Therefore, reduced MYF5 expression may have 
precipitated the reduction of MHC2b and 2x expression in pigs inoculated with PRRSV 
compared with control pigs. Together these data suggest that postnatal PRRSV infection 
increased myostatin expression in the PM, possibly driving decreases in MYF5, MHC2b and 2x 
expression.  
 In muscles of mixed metabolic profiles, myostatin has been associated in the inhibition of 
muscle growth (Escobar et al., 2004); however, increased myostatin expression led to muscle 
atrophy specifically in MHC type 2 muscle fibers (Reardon et al., 2001). The PM is 
metabolically different from the LD as the PM is comprised primarily of oxidative fibers, while 
the LD is comprised primarily of glycolytic fibers (Leseigneur-Meynier and Gandemer, 1991). It 
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can be hypothesized that muscle catabolic events such as infection may have a more profound 
effect on fast, glycolytic muscles than slow, oxidative muscles. As discussed previously, a 
catabolic effect was evident in the PM through an increase in myostatin and reduced MHC2b and 
2x expression. However, in the LD MYOD and myogenin expression were increased. An increase 
in MYOD and myogenin expression is correlated with an increase in myoblasts, satellite cell 
activation, and terminal differentiation (Adams et al., 1999; Smith et al., 1994). This increase in 
myogenic growth factors would stimulate MHC expression supporting the lack of differences in 
MHC expression in the LD of pigs inoculated with PRRSV compared with control pigs.  
Typically, after two to three weeks of acute illness, PRRSV-infected pigs display compensatory 
growth (Benfield et al., 1999). Compensatory growth can be defined as a process by which an 
animal accelerates its growth after a period of restricted development (Hornick et al., 2000). We 
hypothesize the LD displayed signs of compensatory growth, leading to no differences in MHC 
expression while the PM was still inhibited through myostatin production and continued to 
experience a decrease in hypertrophic growth. This suggests that while glycolytic muscle may be 
more susceptible to atrophy, it may also recover more rapidly.  
CONCLUSION 
Similar to previous studies, we concluded that PRRSV infection elicited an 
immunological stress response of increased circulating inflammatory cytokines and decreased 
feed intake and growth. Infection caused a reduction in muscle hypertrophy that resulted in a 
decrease of muscle and body weight. Furthermore, reduced hypertrophy may result from 
increased myostatin expression that reduced myogenic growth factors and decreased MHC 2x 
and 2b expression. In addition, muscles comprised of primarily glycolytic fibers may recover 
more quickly while muscles with a larger percentage of oxidative fibers may be slower to attain 
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compensatory gain after infection. The expected decrease in growth efficiency suggests 
marketing PRRSV infected pigs at lighter weights to minimize feed costs. 
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TABLES 
Table 3.1  Composition of the diet fed to all pigs from 7 days before inoculation to 14 days after 
inoculation (as-fed basis)1 
Item Diet (%) 
Corn 46.13 
Soybean meal 17.50 
Dried whey 14.95 
Distiller’s dried grains with solubles 10.00 
Poultry by-product meal2 7.00 
Choice white grease 1.50 
Ground limestone 0.68 
Monocalcium phosphate 0.27 
Sodium chloride 0.40 
Vitamin and mineral premix4 0.30 
Choline chloride 0.07 
L-Lys HCl 0.60 
DL-Met 0.27 
L-Trp 0.08 
L-Thr 0.15 
L-Val 0.10 
Calculated energy and nutrient composition  
ME, kcal/kg 3,402 
CP, % 22.75 
Standardized ileal digestible AA, %  
Lys 1.38 
Met + Cys 0.83 
Trp 0.26 
Thr 0.86 
Val 0.91 
Ca, % 0.80 
Available P, % 0.40 
1All pigs received a common diet for 7 d immediately following weaning at 3 wk of age. Then 
pigs were provided this diet for the remainder of the trial. 
2Low ash, pet-food-grade poultry by-product meal, American Proteins, Inc., Hanceville, AL 
3AP 920, APC, Inc., Ankeny, IA  
4Vitamin-mineral premix included the following per kilogram of complete diet: Vitamin A 
(retinyl acetate), 11,128 IU; Vitamin D3 (cholecalciferol), 2,204 IU; Vitamin E (dl-α tocopheryl 
acetate), 66 IU; Vitamin K (menadione nicotinamide bisulfite), 1.42 mg; Thiamine (thiamine 
mononitrate), 0.24 mg; Riboflavin, 6.58 mg; Pyridoxine (pyridoxine hydrochloride), 0.24 mg; 
Vitamin B12, 0.03 mg; d-Pantothenic acid (d-calcium pantothenate), 23.5 mg; Niacin 
(nicotinamide and nicotinic acid), 44 mg; Folic acid, 1.58 mg; Biotin, 0.44 mg; Cu (copper 
sulfate), 10 mg; Fe (iron sulfate), 125 mg; I (potassium iodate), 1.26 mg; Mn (manganese 
sulfate), 60 mg; Se (sodium selenite), 0.3 mg; and Zn (zinc oxide), 100 mg. 
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Table 3.2 Taqman primers and probe sequences used for quantitative real-time PCR. 
Gene 
Symbol 
Gene Name 
Gene Bank 
Reference 
Sequence 
Forward Sequence 
Reverse Sequence 
Probe Sequence 
IGF11 
insulin-like 
growth factor 1  
NM_214256.1 
 
IGF22 
insulin-like 
growth factor 2 
NM_213883.2 
CCGTGCTTCCGGACAACT 
AGGTGTCATAGCGGAAGAACTTG 
CCCCAGATACCCCGTGG 
IL-62 interleukin-6 NM_001252429.1 
AACAACCTGAACCTTCCAAAAAT 
TCCACAAGACCGGTGGTGAT 
CAATCAGGAGACCTGCT 
MHC12 
myosin heavy 
chain 1 
NM_001104951.1 
AATGTCCAGCAGGTGATGTATGC 
ATCCGTGTCACCATCCAGTTG 
AGGCCGTGTATGAGAAG 
MHC2a2 
myosin heavy 
chain 2a 
NM_214136.1 
GCAAAAGCGTAATGCTGAAGCT 
CCTCTTCCGTCTGGTAGGTGAGT 
TGCGCAAACATGAGAGG 
MHC2b2 
myosin heavy 
chain 2b 
NM_001123141.1 
GGGTCTTCGGAAACATGAGAGA 
TCCTGCAGCCTGAGAACATTC 
TTACCAGACTGAGGAGGAC 
MHC2x2 
myosin heavy 
chain 2x 
NM_001104951.1 
GGGTCTACGCAAACACGAGAGA 
CAGATCCTGGAGCCTGAGAATG 
AAGGAACTCACTTACCAAAC 
MYF52 
myogenic factor 
5 
NM_001278775.1 
GTCCAGAAAGAGCAGCAGTTTTG 
AGGAGCTTTTATCCGTGGCATAT 
ATCTACTGTCCGGATGTAC 
MYOD1 
myogenic 
differentiation 1 
NM_001002824.1 
 
Myogenin2 Myogenin NM_001012406.1 
GTCCAGAAAGAGCAGCAGTTTTG 
AGGAGCTTTTATCCGTGGCATAT 
ATCTACTGTCCGGATGTAC 
Myostatin2 Myostatin NM_214435.2 
CGACGGAAACGATCATTACCA 
AAGCAGCATTTGGGTTTTCCT 
TACAGAGTCTGATCTTCTAATG 
PAX72 paired box 7 XM_005659088.1 
AGGCAGCAAGCCCAGACA 
CCCTCTTGTACTCCTCAATCTTTTTC 
CGACTCCGGATGTGG 
PRRSV2 PRRSV AY150312 
CGCACCAGATGGGACCTACTT 
ACGGTGTTCAGTGAGGGCTTT 
CGCTGCGTTGACTGG 
RPL 192 
ribosomal protein 
L19 
XM_003131509.3 
TGACCGCCACATGTATCACAGT 
TGTGGATGTGCTCCATGAGAA 
TGTACCTGAAAGTGAAGGG 
TNF-α2 
tumor necrosis 
factor 
NM_214022.1 
TGACCGCCACATGTATCACAGT 
TGTGGATGTGCTCCATGAGAA 
TGTACCTGAAAGTGAAGGG 
1 ABI Assay ID: IGF1 = Ss03394499_m1, MYOD = Ss03378464_u1, UCP3 = 
Ss03391403_m1 
2Custom design assay  
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Table 3.3   Effects of porcine reproductive and respiratory virus 
(PRRSV) infection on growth performance of pigs.1  
Item Control PRRSV SEM P-Value 
Day -7 to -1     
ADFI, g 446.43 430.65 58.37 0.85 
G:F, kg 0.45 0.29 0.09 0.24 
Day 0 to 7 
ADFI, g 726.75 576.88 47.04 0.04 
G:F, kg 0.73 0.37 0.07 <0.01 
Day 8 to 14 
ADFI, g 1025.13 532.13 42.14 <0.01 
G:F, kg  0.67 0.63 0.06 0.69 
1Values represent least square means of 8 pigs. Pigs were inoculated on 
day 0.  
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Table 3.4 Effects of porcine reproductive respiratory syndrome virus 
(PRRSV) on body length and muscle weights 14 d after inoculation.1 
Item Control PRRSV SEMa P-Value 
Pigs, n 8 8   
Body Length, cm 61.67 54.53 1.40 <0.01 
Longissimus Dorsi, g 343.17 223.36 22.93 <0.01 
Relative weight2 1.98 1.75 0.13 0.20 
Psoas Major, g 71.37 32.39 5.40 <0.01 
Relative weight2 0.41 0.25 0.02 <0.01 
Semitendinosus, g 72.44 43.12 4.67 <0.01 
Relative weight2 0.41 0.34 0.02 0.03 
1 SEM reported as maximum standard error of mean 
2 Muscle weight as a percentage of body weight 
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Table 3.5 Myosin heavy chain and myogenic growth factors 
gene expression in longissimus dorsi muscle of pigs 14 days 
after porcine reproductive respiratory virus (PRRSV) 
inoculation.1  
Item2 Control PRRSV P-Value 
MHC1 1.00 (0.33-2.99) 0.83 (0.28-0.49) 0.80 
MHC2a 1.00 (0.26-3.83) 1.67 (0.44-6.41) 0.57 
MHC2x 1.00 (0.47-2.12) 1.23 (0.58-2.60) 0.68 
MHC2b 1.00 (0.48-2.07) 0.54 (0.26-1.11) 0.22 
IGF1 1.00 (0.53-1.90) 0.92 (0.50-1.67) 0.84 
IGF2 1.00 (0.65-1.54) 0.52 (0.34-0.80) 0.04 
MYF5 1.00 (0.43-2.35) 0.45 (0.19-1.06) 0.18 
MYOD  1.00 (0.66-1.52) 2.71 (1.78-4.12) <0.01 
Myogenin 1.00 (0.64-1.57) 1.86 (1.19-2.91) 0.05 
Myostatin 1.00 (0.41-2.41) 0.98 (0.40-2.36) 0.97 
PAX7 1.00 (0.60-1.67) 0.95 (0.59-1.53) 0.87 
1Values are least squares means of fold changes with 95% 
confidence intervals in parentheses. All values of gene 
expression were compared to that of male control pigs.  
2 Abbreviations: MHC = Myosin Heavy Chain, IGF1 = insulin-
like growth factor 1,  
IGF2 = insulin-like growth factor 2, MYF5 = Myogenic factor 5, 
MYOD = myogenic differentiation 1, PAX7 = paired box 7, 
UCP3 = uncoupling protein 3 
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Table 3.6 Myosin heavy chain and myogenic growth factors 
gene expression in psoas major muscle of pigs 14 days after 
porcine reproductive respiratory virus (PRRSV) inoculation.1 
Item2 Control PRRSV P-Value 
MHC1 1.00 (0.63-1.58) 0.92 (0.58-1.45) 0.78 
MHC2a 1.00 (0.68-1.47) 0.66 (0.45-0.97) 0.13 
MHC2x 1.00 (0.72-1.39) 0.35 (0.25-0.49) <0.01 
MHC2b 1.00 (0.38-2.66) 0.13 (0.05-0.34) 0.01 
IGF1 1.00 (0.61-1.65) 0.47 (0.28-0.77) 0.04 
IGF2 1.00 (0.60-1.66) 1.01 (0.61-1.68) 0.98 
MYF5 1.00 (0.65-1.55) 0.39 (0.25-0.60) 0.01 
MYOD  1.00 (0.74-1.35) 1.10 (0.83-1.47) 0.61 
Myogenin 1.00 (0.75-1.33) 0.98 (0.74-1.30) 0.92 
Myostatin 1.00 (0.69-1.44) 1.59 (1.10-2.29) 0.08 
PAX7 1.00 (0.69-1.45) 0.74 (0.51-1.08) 0.25 
1Values are least squares means of fold changes with 95% 
confidence intervals in parentheses. All values of gene 
expression were compared to that of male control pigs.  
2 Abbreviations: MHC = Myosin Heavy Chain, IGF1 = insulin-
like growth factor 1,  
IGF2 = insulin-like growth factor 2, MYF5 = Myogenic factor 
5, MYOD = myogenic differentiation 1, PAX7 = paired box 7, 
UCP3 = uncoupling protein 3 
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Figure 3.1 Serum TNF-α of PRRSV-inoculated and control pigs at 7 and 14 days after infection 
(DAI). Pigs were subjected to intranasal PRRSV inoculation at 35 days of age (PRRSV), while 
control pigs were intranasal inoculated with a saline solution (Control). Pigs were sacrificed 14 
days after inoculation. Bars represent the standard error of the mean. The main effect of PRRSV 
was significant (**, P<0.05) for TNF-α concentrations after the inoculation. 
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Figure 3.2 Body weight of PRRSV-inoculated and control pigs at 0, 7, and 14 days after 
infection (DAI). Pigs were subjected to intranasal PRRSV inoculation at 35 days of age 
(PRRSV), while control pigs were intranasal inoculated with a saline solution (Control). Pigs 
were sacrificed 14 days after inoculation. Bars represent the standard error of the mean. The 
main effect of PRRSV was significant (**, P<0.05) for weight gain after the inoculation. 
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Figure 3.3 Semitendinosus muscle cell number and size of the semitendinosus in PRRSV-
inoculated pigs and control pigs, 14 d after inoculation. The main effect of PRRSV tended to be 
significant (*, P<0.10) for area of muscle fibers. 
 
